Aristada Injection, Suspension, Extended Release
Pricing Report NDC 65757-402-03

Current NADAC: $1,007.84500 per ML · Effective Aug 19, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Aristada (NDC 65757-402-03) is $1007.84500 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Alkermes, Inc., this medication is distributed in a 1 SYRINGE in 1 CARTON / 2.4 mL in 1 SYRINGE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1,007.84500
Per ML

Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 SYRINGE in 1 CARTON / 2.4 mL in 1 SYRINGE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2016, the NADAC wholesale price for (NDC ) has moved within a range of $655.35500 to $1,007.84500 per ML. Over this 9 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$655.3550 - $1,007.8450
Market Volatility
53.79% Variance
Latest Trend
0.73%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $1007.84500 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $1000.51613 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $1005.88514 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $998.87682 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 01, 2026 $1000.69313 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jan 01, 2026 $1000.69313 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 01, 2026 $1000.69313 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Dec 17, 2025 $944.05013 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 19, 2025 $944.98139 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $945.27453 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Sep 17, 2025 $943.93967 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Aug 20, 2025 $943.85357 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026